At a glance
HIL Applied Medical is developing a new class of ultra-compact, high-performance proton therapy systems. HIL’s breakthroughs technology enables meaningful reduction in the size, complexity, and cost of proton therapy systems, without compromising clinical utility.
Investors
OurCrowd, IBA S.A., and Shanghai Creation Investment
MORE COMPANIES
